DIURALKA

PharmaceuticalGeneral

Dosage Form

Syrup

Therapeutic Group

Antacid, Antiflatulent

Formulation

Each 5ml Contains: - Di-Sodium Hydrogen Citrate Anhydrous BP.. 1.25gm DRAP Registration No. 011943